| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | — | −1.8× | — |
| Price / Book | — | 2.1× | — |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | — | −1.6× | — |
| EV / EBITDA | — | −1.2× | — |
| Earnings yield | — | −14.0% | — |
| Free cash flow yield | — | −9.5% | — |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,282.78 | −1.83% | $1.21T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.58 | −1.51% | $634.52B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.06 | −0.40% | $501.97B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $423.18 | −0.42% | $379.84B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.25 | −2.03% | $355.89B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $155.21 | −0.68% | $279.68B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.53 | −1.18% | $264.48B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $668.50 | −1.19% | $247.18B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $442.66 | −1.03% | $239.32B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.55 | −0.41% | $194.11B | 22.9× | 37.5% | +26.7% |
